Rulemaking Docket |
||
|---|---|---|
|
Date (“E”) for estimated future date |
Information |
| LSA document number | LSA #19-377 | |
| Description of rule | Adds 856 IAC 1-43 concerning ephedrine and pseduoephedrine. This rule will establish requirements concerning the sale of products containing ephedrine and pseudoephedrine by pharmacists. The rule will establish requirements regarding "conversion resistant" and "extraction resistant" products containing ephedrine and pseudoephedrine. |
|
| Notice of intent | ||
| Proposed rule | ||
| Public hearing notice (publication date) |
||
| Economic impact statement | ||
| Public hearing date and location | ||
| IEDC comments | ||
| OSBE comments | ||
| Deadline for comments | ||
| Submit comments Online | ||
| Mailing address for comments | ||
| Comments may be inspected at this location | ||
| Request for public hearing | ||
| Other notices | ||
| Relevant scientific and technical findings | ||
| Adoption of final rule | ||
| Submitted to Attorney General | ||
| Deadline for Attorney General action | ||
| Returned by Attorney General | ||
| Recalled by agency | ||
| Submitted to Governor | ||
| Deadline for Governor’s action (may be extended an additional 15 days) | ||
| Final rule filed with the Indiana Register | ||
| Final rule published in the Indiana Register | ||
| Effective date of rule | ||
| Additional information | ||
| For additional information, contact | ||